Lupin, Boehringer Ingelheim to co-market linagliptin in India
Drug majors Lupin and Boehringer Ingelheim on Wednesday announced a strategic alliance to co-market anti-diabetes drug linagliptin in India.
Oct 14, 2015, 12:04 PM IST
Hikma buys US generic drugmaker Roxane for $2.65bn
London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector`s latest rapid round of consolidation.
Jul 28, 2015, 15:59 PM IST